Identification Generic Name (2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE DrugBank Accession Number DB07955 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE (DB07955) ×  Close Weight Average: 286.122  Monoisotopic: 285.000055902  Chemical Formula C 11 H 12 BrNO 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Chymotrypsin-like elastase family member 1 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as benzoyl derivatives. These are organic compounds containing an acyl moiety of benzoic acid with the formula (C6H5CO-). Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Benzoyl derivatives Direct Parent Benzoyl derivatives Alternative Parents Benzaldehydes  /  Aniline and substituted anilines  /  Carboxylic acid esters  /  Amino acids and derivatives  /  Monocarboxylic acids and derivatives  /  Primary amines  /  Organopnictogen compounds  /  Organobromides  /  Organic oxides  /  Hydrocarbon derivatives  /  Alkyl bromides 
 
 
  show 1 more Substituents Aldehyde  /  Alkyl bromide  /  Alkyl halide  /  Amine  /  Amino acid or derivatives  /  Aniline or substituted anilines  /  Aromatic homomonocyclic compound  /  Aryl-aldehyde  /  Benzaldehyde  /  Benzoyl  /  Carbonyl group  /  Carboxylic acid derivative  /  Carboxylic acid ester  /  Hydrocarbon derivative  /  Monocarboxylic acid or derivatives  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organobromide  /  Organohalogen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary amine 
 
 
  show 14 more Molecular Framework Aromatic homomonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key SMKXVWWBCFWRMP-UHFFFAOYSA-N InChI InChI=1S/C11H12BrNO3/c12-3-4-16-11(15)6-8-1-2-10(13)5-9(8)7-14/h1-2,5,7H,3-4,6,13H2 IUPAC Name 2-bromoethyl 2-(4-amino-2-formylphenyl)acetate SMILES NC1=CC(C=O)=C(CC(=O)OCCBr)C=C1 References General References Not Available External Links PubChem Compound 4634717 PubChem Substance 99444426 ChemSpider 3824992 ZINC ZINC000006815590 PDBe Ligand IBR PDB Entries 9est Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.119 mg/mL ALOGPS logP 1.82 ALOGPS logP 1.49 Chemaxon logS -3.4 ALOGPS pKa (Strongest Basic) 3.14 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 69.39 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 65.75 m 3 ·mol -1 Chemaxon Polarizability 24.82 Å 3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9676 Blood Brain Barrier + 0.9568 Caco-2 permeable + 0.5 P-glycoprotein substrate Non-substrate 0.8282 P-glycoprotein inhibitor I Non-inhibitor 0.7626 P-glycoprotein inhibitor II Non-inhibitor 0.8443 Renal organic cation transporter Non-inhibitor 0.8017 CYP450 2C9 substrate Non-substrate 0.8791 CYP450 2D6 substrate Non-substrate 0.859 CYP450 3A4 substrate Non-substrate 0.7354 CYP450 1A2 substrate Inhibitor 0.6319 CYP450 2C9 inhibitor Non-inhibitor 0.6776 CYP450 2D6 inhibitor Non-inhibitor 0.8974 CYP450 2C19 inhibitor Inhibitor 0.5308 CYP450 3A4 inhibitor Non-inhibitor 0.7325 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.6839 Ames test Non AMES toxic 0.6563 Carcinogenicity Non-carcinogens 0.7736 Biodegradation Not ready biodegradable 0.7755 Rat acute toxicity 2.5187 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9006 hERG inhibition (predictor II) Non-inhibitor 0.8625    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Chymotrypsin-like elastase family member 1 Kind Protein Organism Humans Pharmacological action Unknown General Function Serine-type endopeptidase activity Specific Function Acts upon elastin. Gene Name CELA1 Uniprot ID Q9UNI1 Uniprot Name Chymotrypsin-like elastase family member 1 Molecular Weight 27797.995 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:27 / Updated at June 12, 2020 16:52 